Spots Global Cancer Trial Database for leucovorin
Every month we try and update this database with for leucovorin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors | NCT06139211 | Advanced Solid ... | JS015 Toripalimab Paclitaxel Irinotecan Capecitabine Oxaliplatin Bevacizumab Fluorouracil Leucovorin Gemcitabine Albumin-Bound P... | 18 Years - 75 Years | Shanghai Junshi Bioscience Co., Ltd. | |
| Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma | NCT00335140 | Lymphoma | Rituximab Cytarabine Dexamethasone Leucovorin Methotrexate Procarbazine Vincristine | 18 Years - | Eastern Cooperative Oncology Group | |
| Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)-China Extension | NCT04882241 | Gastric Cancer Gastroesophagea... | Pembrolizumab Placebo Cisplatin Capecitabine 5-fluorouracil Docetaxel Oxaliplatin Leucovorin | 18 Years - | Merck Sharp & Dohme LLC | |
| Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | NCT02296671 | Esophagogastric... | Pemetrexed Oxaliplatin Leucovorin Fluorouracil Germline genoty... | 18 Years - | Washington University School of Medicine | |
| A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer | NCT03522649 | Previously Trea... | Napabucasin Fluorouracil Leucovorin Irinotecan | 18 Years - | 1Globe Biomedical Co., Ltd. | |
| Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers | NCT03515941 | Gastrointestina... | Oxaliplatin Capecitabine Leucovorin 5-fluorouracil radiation | 18 Years - | Baylor College of Medicine | |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | NCT04703101 | Locally Advance... Rectal Adenocar... Stage II Rectal... Stage IIA Recta... Stage IIB Recta... Stage IIC Recta... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... | Capecitabine Fluorouracil Intensity-Modul... Leucovorin Oxaliplatin Quality-of-Life... Surveillance Total Mesorecta... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | NCT03000374 | Rectal Cancer | Panitumumab 5Fluorouracil Oxaliplatin Leucovorin | 18 Years - 74 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | NCT00537823 | Colorectal Canc... Metastases | Cetuximab Bevacizumab Leucovorin Oxaliplatin Fluorouracil | 18 Years - | Washington University School of Medicine | |
| FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer | NCT02063529 | Metastatic Colo... | FOLFOXIRI + Cet... FOLFOXIRI | 18 Years - 65 Years | Sun Yat-sen University | |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia | NCT00136435 | Acute Lymphobla... | prednisone doxorubicin vincristine methotrexate asparaginase dexamethasone cranial radiati... leucovorin cytarabine hydrocortisone 6-mercaptopurin... e. coli L-aspar... | 18 Years - 50 Years | Dana-Farber Cancer Institute | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | NCT04488159 | Colon Cancer St... | Capecitabine Oxaliplatin Fluorouracil Leucovorin Immunoscore® as... Physical exerci... | 18 Years - 100 Years | Medical University of Vienna | |
| Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies | NCT04361708 | Pancreatic Aden... Gastroesophagea... Adenocarcinoma | Oxaliplatin Docetaxel Leucovorin Irinotecan 5-Fluorouracil | 18 Years - | University of Chicago | |
| Study of Magrolimab Given Together With FOLFIRI/BEV in Patients With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) | NCT05330429 | Metastatic Colo... | Magrolimab Bevacizumab Irinotecan Fluorouracil Leucovorin | 18 Years - | Gilead Sciences | |
| Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | NCT00323583 | Adenocarincoma ... Stage III Pancr... Stage IVA Pancr... Stage IVB Pancr... | paclitaxel oxaliplatin leucovorin 5-fluorouracil glutathione calcium and mag... Chemotherapy Chemoprotection Complementary a... | 18 Years - 65 Years | Seattle Cancer Treatment and Wellness Center | |
| A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | NCT02715531 | Solid Tumor | 5-FU Atezolizumab Bevacizumab Gemcitabine Leucovorin Nab-Paclitaxel Oxaliplatin Capecitabine Cisplatin | 18 Years - | Hoffmann-La Roche | |
| Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal Cancer | NCT00233623 | Metastatic Colo... | Iressa (Gefitin... Irinotecan 5Fluorouracil Leucovorin | 18 Years - | AstraZeneca | |
| Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer | NCT00200200 | Hepatic Metasta... Colon Cancer Rectal Cancer | Bevacizumab HAI... HAI plus system... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) | NCT04210115 | Esophageal Squa... Gastroesophagea... Esophageal Aden... | pembrolizumab placebo cisplatin 5-FU radiotherapy leucovorin levoleucovorin oxaliplatin | 18 Years - | Merck Sharp & Dohme LLC | |
| Post Marketing Surveillance Study for ONIVYDE® in South Korea | NCT03446872 | Metastatic Panc... | ONIVYDE 5-fluorouracil Leucovorin | 19 Years - | Servier | |
| Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment | NCT02624726 | Metastatic Colo... | 5 Fluorouracil Leucovorin Irinotecan Aflibercept | 18 Years - | Hellenic Oncology Research Group | |
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC | NCT03665441 | Pancreatic Aden... | eryaspase Gemcitabine plu... Irinotecan plus... | 18 Years - | ERYtech Pharma | |
| Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma | NCT00267865 | AIDS-Related-Pr... | Methotrexate Rituximab Leucovorin | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT) | NCT04447352 | Gastric Cancer Gastroesophagea... | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Cisplatin | 18 Years - 75 Years | Krankenhaus Nordwest | |
| Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt- | NCT04595929 | Peritoneal Carc... Gastric Cancer | Staging laparos... 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Radical surgery PIPAC Adjuvant chemot... | 18 Years - 65 Years | St. Petersburg State Pavlov Medical University | |
| Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies | NCT03043547 | Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... Cholangiocarcin... | nal-IRI 5-FU leucovorin | 18 Years - | AIO-Studien-gGmbH | |
| A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer | NCT05026905 | Phase II, Open-... | Gemcitabine 100... Nab paclitaxel S1 leucovorin Oxaliplatin | 20 Years - | National Health Research Institutes, Taiwan | |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy | NCT01164215 | Colorectal Canc... Diarrhea Neutropenia | fluorouracil leucovorin oxaliplatin | - | UNC Lineberger Comprehensive Cancer Center | |
| A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer | NCT05379595 | Advanced or Met... | Amivantamab Fluorouracil Leucovorin Oxaliplatin Irinotecan | 18 Years - | Janssen Research & Development, LLC | |
| FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | NCT01383538 | Pancreatic Canc... Adenocarcinoma Pancreatic Neop... | FOLFIRINOX, IPI... | 18 Years - | University of California, San Francisco | |
| A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | NCT00422864 | Rectal Cancer | oxaliplatin fluorouracil leucovorin External beam r... | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
| Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | NCT02340949 | Rectal Cancer | Aflibercept 5-Fluoruracil Oxaliplatin Leucovorin | 18 Years - 69 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | NCT01226719 | Colorectal Canc... | Panitumumab Oxaliplatin Irinotecan Leucovorin 5-Fluorouracil | 18 Years - | SCRI Development Innovations, LLC | |
| DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | NCT02415699 | Colorectal Canc... | Fluorouracil Oxaliplatin Leucovorin DC-CIK | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | NCT03764553 | Esophageal Canc... | Liposomal Irino... Carboplatin Capecitabine Oxaliplatin 5-fluorouracil Leucovorin | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Pan Tumor Rollover Study | NCT03899155 | Cancer | Nivolumab Ipilimumab Cabozantinib Trametinib Relatlimab Nivolumab + Rel... Capecitabine Bevacizumab Temozolomide Rucaparib Daratumumab Regorafinib Leucovorin Fluorouracil Oxaliplatin Enzalutamide Sunitinib Pemetrexed Pembrolizumab | 18 Years - | Bristol-Myers Squibb | |
| First in Human Study of AZD9592 in Solid Tumors | NCT05647122 | Advanced Solid ... Carcinoma Non-s... Head and Neck N... Colorectal Neop... | AZD9592 Osimertinib 5-Fluorouracil ... Leucovorin Bevacizumab | 18 Years - | AstraZeneca | |
| Pan Tumor Rollover Study | NCT03899155 | Cancer | Nivolumab Ipilimumab Cabozantinib Trametinib Relatlimab Nivolumab + Rel... Capecitabine Bevacizumab Temozolomide Rucaparib Daratumumab Regorafinib Leucovorin Fluorouracil Oxaliplatin Enzalutamide Sunitinib Pemetrexed Pembrolizumab | 18 Years - | Bristol-Myers Squibb | |
| A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma | NCT01660711 | Pancreatic Aden... | 5 Fluorouracil Leucovorin Irinotecan Oxaliplatin | 18 Years - | NorthShore University HealthSystem | |
| Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer | NCT00036517 | Colorectal Neop... Diarrhea | PHY906 | 18 Years - 75 Years | PhytoCeutica | |
| S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | NCT00109837 | Leukemia | filgrastim cyclophosphamid... cytarabine daunorubicin dexamethasone doxorubicin leucovorin mercaptopurine methotrexate mitoxantrone Asparaginase prednisone thioguanine vincristine radiation thera... allopurinol bactrim | 18 Years - 64 Years | SWOG Cancer Research Network | |
| Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients | NCT01523431 | Metastatic Colo... | Irinotecan Inje... 5-fluorouracil Leucovorin | 18 Years - | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT05032183 | Recurrent Adult... Recurrent B Acu... Recurrent T Acu... Refractory B Ac... Refractory Lymp... Refractory T Ac... | Cyclophosphamid... Cytarabine Dexamethasone Filgrastim-sndz Leucovorin Mercaptopurine Mesna Methotrexate Pegfilgrastim Prednisone Rituximab Tagraxofusp-erz... Vincristine | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | NCT01688336 | Pancreatic Canc... | FOLFIRINOX | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | NCT01374425 | Colorectal Canc... | 5-Fluorouracil Bevacizumab Irinotecan Leucovorin Oxaliplatin Capecitabine | 18 Years - | Genentech, Inc. | |
| A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer | NCT03929666 | HER2-expressing... | ZW25 (Zanidatam... Capecitabine Cisplatin Fluorouracil Leucovorin Oxaliplatin Bevacizumab Gemcitabine | 18 Years - | Jazz Pharmaceuticals | |
| Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | NCT03300544 | Locally Advance... Metastatic Rect... Rectal Adenocar... Stage III Recta... Stage IIIA Rect... Stage IIIB Rect... Stage IIIC Rect... Stage IV Rectal... Stage IVA Recta... Stage IVB Recta... | Capecitabine Fluorouracil Leucovorin Oxaliplatin Radiation Thera... Talimogene Lahe... | 18 Years - | National Cancer Institute (NCI) | |
| FOLFIRINOX for 2nd-line Treatment of BTC | NCT03778593 | Biliary Tract C... | 5-Fluorouracil Leucovorin Irinotecan Oxaliplatin 5% dextrose wat... | 20 Years - | Dong-A University Hospital | |
| Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer | NCT06381154 | Locally Advance... Metastatic Panc... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Biopsy Biospecimen Col... Computed Tomogr... Endoscopic Ultr... Fluorouracil Irinotecan Leucovorin Lymph Node Biop... Magnetic Resona... Oxaliplatin Pembrolizumab Photodynamic Th... Positron Emissi... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
| FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer | NCT01747551 | Esophageal Canc... Gastric Cancer | Oxaliplatin Leucovorin Fluorouracil Ziv-aflibercept | 18 Years - | Dana-Farber Cancer Institute | |
| Sorafenib + mFOLFOX for Hepatocellular Carcinoma | NCT01775501 | Hepatocellular ... | Leucovorin Fluorouracil Oxaliplatin Sorafenib | 18 Years - | Massachusetts General Hospital | |
| Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors | NCT01803282 | Pancreatic Canc... Non-small Cell ... Esophagogastric... Colorectal Canc... Breast Cancer | Andecaliximab Gemcitabine Nab-paclitaxel Carboplatin Pemetrexed Leucovorin Oxaliplatin 5-FU Bevacizumab Irinotecan Paclitaxel | 18 Years - | Gilead Sciences | |
| NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | NCT04371224 | Pancreatic Canc... | Irinotecan Lipo... Capecitabine 5-fluorouracil Leucovorin | 20 Years - | Seoul National University Hospital | |
| Tailoring Treatment in Colorectal Cancer | NCT05401318 | Colorectal Neop... | Tumor tissue sa... | 18 Years - | University Hospital, Akershus | |
| Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | NCT00001239 | Breast Cancer Breast Neoplasm... | FLAC with GM-CS... | - | National Institutes of Health Clinical Center (CC) | |
| A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | NCT03368859 | Cancer | Leucovorin Fluorouracil - ... Bevacizumab Fluorouracil - ... ABT-165 Irinotecan | 18 Years - | AbbVie | |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China | NCT01110941 | Colorectal Canc... | S-1, leucovorin... | 20 Years - 80 Years | Peking University | |
| Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | NCT02340949 | Rectal Cancer | Aflibercept 5-Fluoruracil Oxaliplatin Leucovorin | 18 Years - 69 Years | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | NCT01014767 | Brain Cancer Choroid Plexus ... | Carboplatin Cisplatin Cyclophosphamid... Dactinomycin Doxorubicin Etoposide Irinotecan Leucovorin Methotrexate Temozolomide Vincristine | - | Tufts Medical Center | |
| QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | NCT03387085 | Triple Negative... | Aldoxorubicin H... N-803 ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK for Infusi... avelumab bevacizumab Capecitabine Cisplatin Cyclophosphamid... 5-Fluorouracil Leucovorin nab-Paclitaxel SBRT | 18 Years - | ImmunityBio, Inc. | |
| HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT | NCT04618367 | Carcinoma, Hepa... Liver Neoplasms Sintilimab Portal Vein Tum... | Hepatic arteria... Lenvatinib Sintilimab | 18 Years - 75 Years | Sun Yat-sen University | |
| Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy | NCT00673179 | Osteosarcoma | Doxorubicin Cisplatin Methotrexate Leucovorin Dexrazoxane Ifosfamide Questionnaire Gemcitabine Sargramostim Surgery Mesna | 5 Years - 40 Years | M.D. Anderson Cancer Center | |
| Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | NCT00126191 | Burkitt Lymphom... Non-Hodgkins Ly... Atypical Burkit... | Rituximab Cyclophosphamid... Doxorubicin Vincristine Methotrexate Leucovorin Ifosfamide Etoposide Cytarabine Mesna | 18 Years - | Dana-Farber Cancer Institute | |
| Venetoclax Basket Trial for High Risk Hematologic Malignancies | NCT05292664 | Myelodysplastic... Myelodysplastic... Myelodysplastic... Treatment-Relat... Therapy-Related... Acute Lymphobla... Acute Lymphobla... Lymphoblastic L... Lymphoblastic L... Acute Leukemia ... Acute Leukemia ... | Venetoclax Azacitidine Cytarabine Methotrexate Hydrocortisone Leucovorin Dexamethasone Vincristine Doxorubicin Dexrazoxane Calaspargase Pe... Erwinia asparag... | 1 Year - 40 Years | Dana-Farber Cancer Institute | |
| Study of Magrolimab Given Together With FOLFIRI/BEV in Patients With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) | NCT05330429 | Metastatic Colo... | Magrolimab Bevacizumab Irinotecan Fluorouracil Leucovorin | 18 Years - | Gilead Sciences | |
| Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols | NCT04299880 | Oncology | Napabucasin Nab-paclitaxel Gemcitabine Nivolumab Paclitaxel Irinotecan Leucovorin 5Fluorouracil Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | NCT02545504 | Gastric Adenoca... | Andecaliximab Placebo Leucovorin 5-fluorouracil Oxaliplatin | 18 Years - | Gilead Sciences | |
| HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | NCT05493332 | Hepatocellular ... | HAIC(FOLFOX) Oxaliplatin Leucovorin Fluorouracil Toripalimab Donafenib | 18 Years - 75 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread | NCT04233866 | Metastatic Panc... Stage IV Pancre... | Fluorouracil Gemcitabine Gemcitabine Hyd... Leucovorin Leucovorin Calc... Liposomal Irino... Nab-paclitaxel Quality-of-Life... Questionnaire A... | 70 Years - | Eastern Cooperative Oncology Group | |
| METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin | NCT03388190 | Colorectal Canc... | Nivolumab FLOX | 18 Years - | University Hospital, Akershus | |
| Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | NCT00044785 | Solid Tumors | triacetyluridin... fluorouracil leucovorin camptosar | 18 Years - | Wellstat Therapeutics | |
| mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | NCT03043729 | Rectal Cancer Rectosigmoid Ca... | Oxaliplatin 5-FU Leucovorin Aflibercept | 18 Years - | AIO-Studien-gGmbH | |
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT05688215 | Borderline Rese... Locally Advance... | Biospecimen Col... Computed Tomogr... Core Biopsy Fluorouracil Irinotecan Leucovorin Leucovorin Calc... Oxaliplatin Quemliclustat Zimberelimab | 18 Years - | Jonsson Comprehensive Cancer Center | |
| 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | NCT01216644 | Gastric Cancer | 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel Epirubicin Cisplatin 5-fluorouracil | 18 Years - | Krankenhaus Nordwest | |
| For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy | NCT00037180 | Neoplasm Metast... Colorectal Neop... | Celecoxib Irinotecan 5-fluorouracil Leucovorin | 18 Years - | Pfizer | |
| A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | NCT01246960 | Stomach Cancer Esophageal Canc... | Ramucirumab Placebo Oxaliplatin Leucovorin 5-Fluorouracil | 18 Years - | Eli Lilly and Company | |
| mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | NCT03043729 | Rectal Cancer Rectosigmoid Ca... | Oxaliplatin 5-FU Leucovorin Aflibercept | 18 Years - | AIO-Studien-gGmbH | |
| A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | NCT00009737 | Colorectal Canc... | 5-Fluorouracil Leucovorin Capecitabine [X... | 18 Years - 75 Years | Hoffmann-La Roche | |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer | NCT03203525 | Advanced Malign... Colorectal Carc... Metastatic Mali... Refractory Mali... | Bevacizumab Fluorouracil Leucovorin Oxaliplatin Pegylated Lipos... Temsirolimus Tumor Treating ... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
